GlassScriptPhysician profile
Stephen N Makoni
NPI 1073544532
$35,701.23
in general payments reported to CMS, 2019-2025
86 companies · $12K in 2025
The $12K reported for 2025 was more than what 90% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,270 · 2020: $3,520 · 2021: $4,347 · 2022: $3,197 · 2023: $6,379 · 2024: $5,095 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Food and Beverage: $9,442 · Education: $603 · Travel and Lodging: $315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,007.50 |
| Food and Beverage | $9,442.10 |
| Education | $602.59 |
| Travel and Lodging | $315.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $9,678.77 | 2019-2025 | Imfinzi, Tagrisso, Enhertu |
| Geron Corporation | $3,083.87 | 2025 | Imetelstat, Rytelo |
| Glaxosmithkline, LLC. | $2,139.00 | 2020-2025 | Zejula, Ojjaara, Jemperli |
| Taiho Oncology, INC. | $1,876.74 | 2023-2025 | |
| Exelixis INC. | $1,730.41 | 2019-2025 | Cabometyx |
| Beigene USA, INC. | $1,573.86 | 2020-2025 | Tevimbra, Brukinsa |
| Daiichi Sankyo INC. | $1,326.89 | 2020-2025 | Enhertu, Datroway, Injectafer |
| Merck Sharp & Dohme LLC | $1,150.83 | 2019-2025 | Keytruda, Welireg, Reblozyl |
| Janssen Biotech, INC. | $1,020.65 | 2019-2025 | Erleada, Tecvayli, Darzalex |
| Pfizer INC. | $941.67 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $832.85 | 2019-2025 | |
| Celgene Corporation | $737.43 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| E.R. Squibb & Sons, L.L.C. | $667.12 | 2019-2025 | Opdivo, Reblozyl, Krazati |
| Genzyme Corporation | $618.16 | 2019-2025 | |
| Seagen INC. | $493.06 | 2019-2025 | Tukysa, Tivdak |
Show all 86 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $483.16 | 2019-2025 | Jakafi, Monjuvi, Zynyz |
| Eisai INC. | $422.46 | 2020-2025 | |
| Lilly USA, LLC | $400.69 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Takeda Pharmaceuticals U.S.A., INC. | $371.93 | 2019-2024 | Iclusig, Ninlaro, Alunbrig |
| Abbvie INC. | $339.61 | 2019-2025 | |
| Astellas Pharma US INC | $317.45 | 2020-2025 | Xtandi, Vyloy, Xospata |
| Genentech USA, INC. | $299.34 | 2020-2025 | Tecentriq, Polivy, Lunsumio |
| Sobi, INC | $244.21 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $239.29 | 2020-2025 | |
| Sirtex Medical INC | $233.06 | 2020-2023 | Sir-Spheres Microspheres |
| Dova Pharmaceuticals | $229.77 | 2019-2021 | |
| Pharmacyclics LLC, An Abbvie Company | $221.64 | 2019-2023 | Imbruvica, Epkinly |
| Array Biopharma INC | $220.56 | 2022-2025 | Braftovi, Lorbrena, Mektovi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $204.90 | 2019-2025 | |
| Beone Medicines USA, INC. | $204.86 | 2025 | Tevimbra, Brukinsa |
| Jazz Pharmaceuticals INC. | $195.86 | 2020-2025 | |
| Puma Biotechnology, INC. | $181.04 | 2019-2025 | Nerlynx |
| Amgen INC. | $178.08 | 2019-2023 | Lumakras |
| Alexion Pharmaceuticals, INC. | $176.77 | 2024-2025 | Ultomiris |
| Regeneron Healthcare Solutions, INC. | $170.37 | 2019-2025 | Libtayo, Lynozyfic |
| Emd Serono, INC. | $141.55 | 2022-2025 | Bavencio |
| Penumbra, INC. | $141.35 | 2021 | |
| Progenics Pharmaceuticals, INC. | $127.48 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $125.48 | 2019-2025 | Onivyde, Tazverik, Somatuline Depot |
| Tersera Therapeutics LLC | $118.51 | 2021-2025 | Zoladex |
| Tempus Ai, INC | $103.02 | 2025 | Xt Cdx |
| Karyopharm Therapeutics INC. | $99.47 | 2023-2024 | Xpovio |
| Mirati Therapeutics, INC. | $89.60 | 2023-2024 | Krazati |
| Adc Therapeutics America, INC. | $89.34 | 2023-2025 | |
| Stemline Therapeutics INC. | $81.04 | 2025 | Orserdu |
| Rigel Pharmaceuticals, INC. | $68.19 | 2020-2025 | Rezlidhia, Tavalisse, Gavreto |
| Janssen Pharmaceuticals, INC | $67.24 | 2020-2025 | |
| Integra Lifesciences Corporation | $63.83 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kyowa Kirin, INC. | $62.98 | 2020-2023 | Poteligeo |
| Kite Pharma, INC. | $60.33 | 2022-2025 | Yescarta |
| Adaptive Biotechnologies Corporation | $57.99 | 2022-2025 | Clonoseq |
| Morphosys, US INC. | $57.37 | 2021-2023 | Monjuvi |
| Abbott Laboratories | $56.32 | 2024 | Jeti Peripheral Catheter |
| Global Blood Therapeutics, INC. | $55.11 | 2021-2022 | |
| Aveo Pharmaceuticals, INC. | $54.15 | 2021-2025 | |
| Myriad Genetic Laboratories, INC. | $45.93 | 2024 | Precisetumor |
| Pharmacosmos Therapeutics INC. | $45.12 | 2024 | Monoferric |
| Immunogen, INC. | $42.78 | 2023 | Elahere |
| Mylan Institutional INC. | $40.73 | 2019-2022 | |
| Alnylam Pharmaceuticals INC. | $40.68 | 2023-2024 | Givlaari |
| Agios Pharmaceuticals, INC. | $36.26 | 2022 | |
| Organon LLC | $33.07 | 2022 | |
| Caris Mpi, INC. | $32.00 | 2025 | Mi Cancer Seek |
| Iovance Biotherapeutics, INC. | $31.41 | 2025 | Amtagvi |
| Shield Therapeutics INC | $28.09 | 2024 | |
| Pharmaessentia USA Corporation | $25.90 | 2024 | Besremi |
| Fennec Pharmaceuticals, INC. | $23.92 | 2024 | Pedmark |
| Amneal Pharmaceuticals LLC | $23.08 | 2025 | Pemryri Rtu |
| Deciphera Pharmaceuticals INC. | $22.61 | 2023 | Qinlock |
| Octapharma USA, INC. | $22.08 | 2022 | |
| Fortovia Therapeutics, INC. | $21.46 | 2019 | |
| Servier Pharmaceuticals LLC | $20.83 | 2023 | |
| Tg Therapeutics, INC. | $20.20 | 2022 | |
| Epizyme, INC. | $19.70 | 2022 | |
| Advanced Accelerator Applications | $18.73 | 2020 | |
| Apellis Pharmaceuticals, INC. | $18.56 | 2024 | Empaveli |
| Clovis Oncology, INC. | $18.52 | 2020 | |
| Ethicon INC. | $18.21 | 2020 | |
| Novo Nordisk INC | $17.30 | 2019 | |
| Recordati_rare_diseases_inc. | $16.53 | 2024 | Sylvant |
| Legend Biotech USA INC. | $15.99 | 2025 | Carvykti |
| Sun Pharmaceutical Industries INC. | $15.97 | 2021 | |
| Azurity Pharmaceuticals, INC. | $15.95 | 2025 | Vivimusta |
| Amag Pharmaceuticals, INC. | $15.80 | 2019 | |
| Emmaus Medical, INC. | $15.19 | 2020 | |
| Gilead Sciences, INC. | $11.92 | 2021 |
Drugs and devices associated with these payments
Imfinzi $7,297Imetelstat $3,061Lonsurf $1,877Tevimbra $1,589Keytruda $616Enhertu $455Erleada $423Reblozyl $364Xtandi $329Lenvima $277Tecvayli $232Opdivo $230Jakafi $208Lynparza $207Tagrisso $200Darzalex $194Pluvicto $192Integra $191Venclexta $190Talzenna $190Tukysa $189Lorbrena $182Ultomiris $177Braftovi $177Sarclisa $163Imbruvica $151Kisqali $139Brukinsa $137Mektovi $136Tecentriq $136Talvey $134Nubeqa $132Inlyta $130Bavencio $125Verzenio $125Datroway $124Libtayo $122Jaypirca $121Welireg $115Cabometyx $113Xofigo $113Krazati $111Epkinly $109Bosulif $103Xt Cdx $103Lutathera $102Orgovyx $101Akeega $99.67Balversa $99.67Xpovio $99.47Zoladex $94.08Zejula $89.05Comirnaty $88.79Paxlovid $88.69Oxbryta $86.82Ojjaara $83.89Padcev $83.15Elrexfio $82.05Adcetris $82.05Orserdu $81.04Elahere $76.89Inqovi $76.74Xalkori $76.55Ibrance $70.71Jemperli $69.71Vonjo $66.63Monjuvi $66.13Iclusig $65.50Onivyde $64.65Pomalyst $64.07Integra Dermal Regeneration Template $63.83Primatrix $63.83Zepzelca $62.91Opdualag $58.76Injectafer $57.31Zynlonta $56.50Jeti Peripheral Catheter $56.32Tavalisse $55.16Rezlidhia $55.16Ninlaro $52.67Vyloy $50.49Precisetumor $45.93Keytruda Qlex $45.20Monoferric $45.12Yescarta $43.02Clonoseq $42.79Doptelet $42.68Retevmo $41.45Givlaari $40.68Nerlynx $39.33Stivarga $38.65Vitrakvi $38.65Fotivda $38.31Scemblix $33.86Mi Cancer Seek $32.00Gavreto $31.44Amtagvi $31.41Xospata $29.56Jevtana $28.68Accrufer $28.09
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Makoni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.